Literature DB >> 31651373

Correction to: Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.

William Sones1, Steven A Julious2, Joanne C Rothwell2, Craig Robert Ramsay3, Lisa V Hampson4,5, Richard Emsley6, Stephen J Walters2, Catherine Hewitt7, Martin Bland7, Dean A Fergusson8, Jesse A Berlin9, Doug Altman1, Luke David Vale10, Jonathan Alistair Cook11.   

Abstract

Following publication of the original article [1], we have been notified of a few mistakes.

Entities:  

Year:  2019        PMID: 31651373      PMCID: PMC6813096          DOI: 10.1186/s13063-019-3809-2

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


Correction to: Trials (2018) 19:542 https://doi.org/10.1186/s13063-018-2887-x Following publication of the original article [1], we have been notified of a few mistakes: Figure 1: “1351 titles and abstracts” should read “1322 titles and abstracts” "Stat Biopharm Res" value should be "8" instead of "18" "Stat Med" value should be "226" instead of "74" "Stat Methods Med Res" value should be "74" instead of "226" Results section, Stage 5, first paragraph, the phrase: “It was endorsed by the MRC-NIHR Methodology Advisory Group on March 12, 2018, with minor updating of references and the final version produced on April 18, 2017” should read “It was endorsed by the MRC-NIHR Methodology Advisory Group on March 12, 2018, with minor updating of references and the final version produced on April 18, 2018”.
  1 in total

1.  Choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial - the development of the DELTA2 guidance.

Authors:  William Sones; Steven A Julious; Joanne C Rothwell; Craig Robert Ramsay; Lisa V Hampson; Richard Emsley; Stephen J Walters; Catherine Hewitt; Martin Bland; Dean A Fergusson; Jesse A Berlin; Doug Altman; Luke David Vale; Jonathan Alistair Cook
Journal:  Trials       Date:  2018-10-10       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.